Inscopix is an innovative neurotechnology company commercializing a technology platform to drive a mechanistic understanding of the brain. Inscopix’s technology stack is in use at >500 sites across the world, primarily at academic institutions, and has generated >150 publications with most in Cell, Science, and Nature family of journals. Recently, thanks to increasingly translationally-relevant data from Inscopix’s users and inbound interest from Pharma / Biotech, Inscopix has built-out a small team and facilities to conduct translationally-relevant R&D and to collaborate with Pharma / Biotech on therapeutic development projects. We are seeking a Chief Scientific Officer (CSO) to take this build-out and effort to the next level. The CSO will define and execute on a vision to revolutionize the understanding and treatment of brain disease and mental illness. The CSO will be responsible for establishing the Company’s scientific research roadmap, and leveraging a team of talented scientists and current research activities, will build internal and external R&D programs to support translationally-relevant objectives. This role will report to the Chief Executive Officer. The CSO will be a key member of Inscopix’s Executive Team and a partner with the CEO and the founding team in executing on a broader vision focused on human impact.
Decoding the neural language of the brain is the defining scientific challenge and opportunity of the 21st Century. Inscopix is a discovery phase neurotechnology company based in Palo Alto developing a platform and full stack for real-time brain mapping. Our team brings together deep domain expertise in neuroscience, physics, engineering, software development, and data science and is enabling radically new approaches to understanding the brain in health and disease. Inscopix’s neurotechnologies and the knowledge that they foster will transform human existence, from alleviating the suffering caused by debilitating brain disorders, to the development of advanced artificial intelligence, to a more profound understanding of what makes us human. nVista and nVoke, our flagship products, are in use today at over 350 research institutions across the world, and have resulted in over 65 top-tier scientific publications on learning, memory, cognition, and on the brain circuits implicated in diseases such as Parkinson’s. Our instrumentation products are accompanied with sophisticated data analysis software as part of end-to-end solutions for generating and analyzing brain activity data. Inscopix has been recognized as a World Economic Forum Technology Pioneer, and by Deloitte as one of North America’s fastest growing technology companies.
Inscopix is an equal employment opportunity employer.